CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases.
CellVoyant has raised €8.8M across 1 funding round from 4 investors, most recently a round in Jan 2024. Based in Bristol, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-16 | Other | €8.8M |
| Air Street Capital,Horizons Ventures,Octopus Ventures,Verve Ventures |
| View deal → |
